Sitaneu 50 Mg Tablet 15 - Uses, Side Effects, Dosage, Price

About Sitaneu 50 Tablet 15

Sitaneu 50 Tablet 15 is used in managing type 2 diabetes by improving insulin sensitivity and reducing glucose production to maintain healthy blood sugar levels. It helps lower the risk of serious diabetes complications such as kidney damage, neuropathy, vision loss, and heart issues.

Take this medicine exactly as prescribed and inform your doctor about any health conditions or medications. Report any side effects immediately and continue taking the tablet for the recommended duration to ensure effective blood sugar control.

What is Sitaneu 50 Tablet 15 used for?

Sitaneu 50 Tablet 15 is used to manage high blood sugar in adults with type 2 diabetes when diet, exercise, and single medicinal therapy are inadequate.

How does Sitaneu 50 Tablet 15 work?

Sitaneu 50 Tablet 15 contains sitagliptin, which works by regulating insulin levels and controlling high blood sugar.

Can I take Sitaneu 50 Tablet 15 with other antidiabetic medicines?

Yes, Sitaneu 50 Tablet 15 can be taken with other antidiabetic medications, such as metformin and sulfonylureas, but always consult your doctor first.

Are there any side effects of taking Sitaneu 50 Tablet 15?

Common side effects include upper respiratory tract infection, nasopharyngitis, headaches, and hypoglycaemia.

How should I take Sitaneu 50 Tablet 15?

Take Sitaneu 50 Tablet 15 orally as advised by your doctor. It can be taken with or without food at any time of the day.

What precautions should I take while using Sitaneu 50 Tablet 15?

Inform your doctor if you have or have ever had pancreatitis, gallstones, kidney disease, heart disease, or high triglyceride levels before starting this medicine.

Can I drink alcohol while on Sitaneu 50 Tablet 15?

Alcohol can increase the risk of hypoglycaemia, especially if you are already taking other antidiabetic medicines. It is advisable to avoid consuming alcohol while on Sitaneu 50 Tablet 15.

References

U.S. Food and Drug Administration. (2023, Oct). Zituvio (sitagliptin) tablets label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211566s000lbl.pdf
U.S. Food and Drug Administration. (2022, Jun). Januvia (sitagliptin) tablets label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021995s050lbl.pdf
U.S. Food and Drug Administration. (2006, Oct 16). Drug Approval Package - Januvia (sitagliptin phosphate) tablets. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021995s000TOC.cfm
AHFS Patient Medication Information [Internet]. (2024, Feb 15). Sitagliptin – MedlinePlus Drug Information. U.S. National Library of Medicine. https://medlineplus.gov/druginfo/meds/a606023.html
National Center for Biotechnology Information (2024). PubChem Compound Summary for CID 4369359, Sitagliptin. https://pubchem.ncbi.nlm.nih.gov/compound/Sitagliptin
Scott L. J. (2017). Sitagliptin: A Review in Type 2 Diabetes. Drugs, 77(2), 209–224. https://doi.org/10.1007/s40265-016-0686-9
Gallwitz B. (2007). Review of sitagliptin phosphate: a novel treatment for type 2 diabetes. Vascular health and risk management, 3(2), 203–210. https://doi.org/10.2147/vhrm.2007.3.2.203

Disclaimer

We, at Truemeds make a diligent attempt to deliver accurate, expert- drafted and thoroughly reviewed medicine related information to our consumers. However, it should, by no means, be considered a substitute for prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact we detest any form of self medication without expert advice. The sole purpose of the information on our portal is to educate our consumers, which helps improve the communication between a doctor and a patient. The information by no means is complete in its entirety and should not be used to diagnose or treat any medical condition. No amount of information can replace the experience and expertise of a doctor, therefore his/her advice always holds priority and should be followed appropriately.